(Q50571679)

English

Efficacy of low dose long-term interferon monotherapy in aged patients with chronic hepatitis C genotype 1 and its relation to alpha-fetoprotein: A pilot study.

scientific article published in July 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/17539990

Efficacy of low dose long-term interferon monotherapy in aged patients with chronic hepatitis C genotype 1 and its relation to alpha-fetoprotein: A pilot study. (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/17539990

chronic hepatitis C

1 reference

based on heuristic

inferred from title

author name string

Hideyuki Nomura

1

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/17539990

Yoichiro Kashiwagi

2

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/17539990

Ryouko Hirano

3

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/17539990

Hironori Tanimoto

4

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/17539990

Nobuo Tsutsumi

5

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/17539990

Masashi Higashi

6

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/17539990

Hiromi Ishibashi

7

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/17539990

publication date

1 July 2007

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/17539990

Hepatology Research

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/17539990

37

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/17539990

7

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/17539990

490-497

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/17539990

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2007.00073.X

21 January 2018

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2007.00073.X

21 January 2018

Factors contributing to ribavirin-induced anemia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2007.00073.X

21 January 2018

Impact of obesity on treatment of chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2007.00073.X

21 January 2018

Hepatic steatosis is a predictor of poor response to interferon alpha-2b and ribavirin combination therapy in Japanese patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2007.00073.X

21 January 2018

A multivariate analysis of risk factors for hepatocellular carcinogenesis: a prospective observation of 795 patients with viral and alcoholic cirrhosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2007.00073.X

21 January 2018

Pretreatment viral load and response to prolonged interferon-alpha course for chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2007.00073.X

21 January 2018

Significance of serum hepatitis C virus RNA levels in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2007.00073.X

21 January 2018

Predictors of the efficacy of interferon therapy in chronic hepatitis C virus infection. Tokyo-Chiba Hepatitis Research Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2007.00073.X

21 January 2018

The effects of a high dose, short course of interferon on hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2007.00073.X

21 January 2018

Interferon therapy reduces the risk for hepatocellular carcinoma: national surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan. IHIT Study Group. Inhibition of Hepatocarcinogenesis by Interferon Therapy.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2007.00073.X

21 January 2018

Effect of interferon therapy on hepatocellular carcinogenesis in patients with chronic hepatitis type C: A long-term observation study of 1,643 patients using statistical bias correction with proportional hazard analysis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2007.00073.X

21 January 2018

Newer markers for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2007.00073.X

21 January 2018

Identifiers

10.1111/J.1872-034X.2007.00073.X

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/17539990

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/17539990

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50571679&oldid=1540626941"